ProtAffin AG appoints Dr Mike Bartley as Chief Development Officer
Prior to joining ProtAffin, Dr. Bartley worked for 10 years at Pfizer Inc. in the UK as a Senior Project Leader for pre-clinical and clinical projects. He most recently led early clinical-stage projects in respiratory diseases at Pfizer, taking several anti-inflammatory candidates with novel mechanisms of action into the clinic. Dr. Bartley studied at Imperial College London and was awarded a PhD by Queen Mary College London, before joining ICI (Zeneca, Syngenta) agrochemicals, where he led projects in many R&D areas, several of which progressed to product launch.
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.